Survival outcomes of patients with resectable pancreatic cancer treated with upfront surgery versus neoadjuvant chemotherapy: A retrospective tertiary care center experience.

被引：0
作者：
Liu, Fang
Mirsky, Matthew
Wu, Sulin
Fu, Pingfu
Cao, Shufen
Shanahan, John
Kyasaram, Ravi Kumar
Jain, Prantesh
Hardacre, Jeffrey
Ammori, John Brian
Winter, Jordan Michael
Bajor, David Lawrence
机构：
[1] Univ Hosp, Cleveland, OH USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Biostats & Epidemiol, Cleveland, OH 44106 USA
[5] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[6] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4623
引用
收藏
页数：2
相关论文
共 50 条
[41]   Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma [J].
Hu, Qiancheng ;
Wang, Dan ;
Chen, Ye ;
Li, Xiaofen ;
Cao, Peng ;
Cao, Dan .
RADIATION ONCOLOGY, 2019, 14 (1)
[42]   Letter to "Identification of Pre-Operative Risk Factors for Poor Survival in Patients with Resectable Pancreatic Cancer Treated with Upfront Surgery" [J].
Verma, Harshit ;
Jha, Ashesh Kumar ;
Kumar, Manoj ;
Singh, Prashant Kumar ;
Kumar, Anil ;
Paswan, Shiv Shankar ;
Kumar, Deepak .
DIGESTIVE SURGERY, 2023, 39 (04) :201-202
[43]   Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials [J].
Ghanem, I. ;
Lora, D. ;
Herradon, N. ;
de Velasco, G. ;
Carretero-Gonzalez, A. ;
Jimenez-Varas, M. A. ;
de Parga, P. Vazquez ;
Feliu, J. .
ESMO OPEN, 2022, 7 (03)
[44]   Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma [J].
Qiancheng Hu ;
Dan Wang ;
Ye Chen ;
Xiaofen Li ;
Peng Cao ;
Dan Cao .
Radiation Oncology, 14
[45]   Neoadjuvant chemotherapy versus upfront surgery in early pancreatic cancer- are we any wiser in 2024? [J].
Maloney, Sarah ;
Pavlakis, Nick ;
Clarke, Stephen ;
Samra, Jaswinder ;
Mittal, Anubhav ;
Sahni, Sumit .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 :95-95
[46]   Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery [J].
Barnes, Chad A. ;
Chavez, Mariana, I ;
Tsai, Susan ;
Aldakkak, Mohammed ;
George, Ben ;
Ritch, Paul S. ;
Dua, Kulwinder ;
Clarke, Callisia N. ;
Tolat, Parag ;
Hagen, Catherine ;
Hall, William A. ;
Erickson, Beth A. ;
Evans, Douglas B. ;
Christians, Kathleen K. .
SURGERY, 2019, 166 (03) :277-285
[47]   Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis [J].
Bradley, Alison ;
Van Der Meer, Robert .
SCIENTIFIC REPORTS, 2019, 9 (1)
[48]   Neoadjuvant Treatment versus Upfront Surgery for Primary Resectable Pancreatic Cancer: An Update Meta-Analysis of Comparative Studies [J].
Roesel, R. ;
Cristaudi, A. ;
Deantonio, L. ;
de Dosso, S. ;
Berneardi, L. .
BRITISH JOURNAL OF SURGERY, 2023, 110 (SUPP 5)
[49]   Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis [J].
Alison Bradley ;
Robert Van Der Meer .
Scientific Reports, 9
[50]   COMPARISON BETWEEN NEOADJUVANT CHEMOTHERAPY AND UPFRONT SURGERY FOR PATIENTS WITH RESECTABLE AND SYNCHRONOUS COLORECTAL CANCER HEPATIC METASTASES. [J].
Lee, J. ;
Han, Y. ;
Cho, M. ;
Hur, H. ;
Lee, K. ;
Kim, N. ;
Min, B. .
DISEASES OF THE COLON & RECTUM, 2019, 62 (06) :E266-E267
12345